Literature DB >> 12830135

The establishment and maintenance of lymphocyte identity through gene silencing.

Stephen T Smale1.   

Abstract

Cell identity is determined by selective gene activation and by the maintenance of other regulated genes in a silent state. Although activation mechanisms have been dissected in considerable depth, great strides towards an understanding of the molecular control of gene silencing have been made only recently. Molecular hallmarks of silent chromatin and proteins involved in its assembly and maintenance have been identified through genetic, cytological and biochemical studies in a variety of organisms. Immunologists are now beginning to use this knowledge to elucidate mechanisms underlying cell fate decisions and key developmental steps. This review surveys the current knowledge of gene silencing, with an emphasis on studies in lymphocytes that are advancing our general understanding of silencing mechanisms during development.

Mesh:

Substances:

Year:  2003        PMID: 12830135     DOI: 10.1038/ni0703-607

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  23 in total

1.  Site-specific expression of polycomb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomas.

Authors:  Frank M Raaphorst; Maarten Vermeer; Elly Fieret; Tjasso Blokzijl; Danny Dukers; Richard G A B Sewalt; Arie P Otte; Rein Willemze; Chris J L M Meijer
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

2.  Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.

Authors:  Yefei Han; Kara Lassen; Daphne Monie; Ahmad R Sedaghat; Shino Shimoji; Xiao Liu; Theodore C Pierson; Joseph B Margolick; Robert F Siliciano; Janet D Siliciano
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  ETO2 coordinates cellular proliferation and differentiation during erythropoiesis.

Authors:  Nicolas Goardon; Julie A Lambert; Patrick Rodriguez; Philippe Nissaire; Sabine Herblot; Pierre Thibault; Dominique Dumenil; John Strouboulis; Paul-Henri Romeo; Trang Hoang
Journal:  EMBO J       Date:  2006-01-12       Impact factor: 11.598

4.  Targets of the Tal1 transcription factor in erythrocytes: E2 ubiquitin conjugase regulation by Tal1.

Authors:  Jörn Lausen; Ole Pless; Fransisca Leonard; Olga N Kuvardina; Benjamin Koch; Achim Leutz
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

5.  MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance.

Authors:  Mohamed El Gazzar; Charles E McCall
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

Review 6.  Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.

Authors:  Sonia Shah; Michael R Nonnemacher; Vanessa Pirrone; Brian Wigdahl
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

Review 7.  Axotrophin and leukaemia inhibitory factor (LIF) in transplantation tolerance.

Authors:  Su M Metcalfe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

8.  Chromatin condensation via the condensin II complex is required for peripheral T-cell quiescence.

Authors:  Jason S Rawlings; Martina Gatzka; Paul G Thomas; James N Ihle
Journal:  EMBO J       Date:  2010-12-17       Impact factor: 11.598

9.  Epigenetic silencing of the c-fms locus during B-lymphopoiesis occurs in discrete steps and is reversible.

Authors:  Hiromi Tagoh; Alexandra Schebesta; Pascal Lefevre; Nicola Wilson; David Hume; Meinrad Busslinger; Constanze Bonifer
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

10.  S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase.

Authors:  Robert Wuerffel; Lili Wang; Fernando Grigera; John Manis; Erik Selsing; Thomas Perlot; Frederick W Alt; Michel Cogne; Eric Pinaud; Amy L Kenter
Journal:  Immunity       Date:  2007-11-01       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.